Clinical Trial Update: Shingrix in Patients With Rheumatic Diseases: a Double-blind Placebo-controlled RCT [Phase 4]

View source ↗

Summary

Phase 4 double-blind, placebo-controlled randomized trial evaluating Shingrix in patients with rheumatic diseases; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Shingrix (recombinant zoster vaccine, adjuvanted)

Snippet

Sponsor: Tuen Mun Hospital | Conditions: Herpes Zoster | Phase 4 | Status: NOT_YET_RECRUITING